Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

By Seliger Barbara  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1719-1726

Springer Publishing Company

Access to resources Recommend Favorite

NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy

By Neal Zane   Imboden Michael   Rakhmilevich Alexander   Kim Kyung-Mann   Hank Jacquelyn   Surfus Jean   Dixon John   Lode Holger   Reisfeld Ralph   Gillies Stephen   Sondel Paul  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 1, 2004-01 ,pp. : 41-52

Springer Publishing Company

Access to resources Recommend Favorite

Expression of MHC I and NK ligands on human CD133 + glioma cells: possible targets of immunotherapy

By Wu Anhua   Wiesner Steve   Xiao Jing   Ericson Katya   Chen Wei   Hall Walter   Low Walter   Ohlfest John  

Journal of Neuro-Oncology, Vol. 83, Iss. 2, 2007-06 ,pp. : 133-133

Springer Publishing Company

Access to resources Recommend Favorite

Expression of MHC I and NK ligands on human CD133⁺ glioma cells: possible targets of immunotherapy

By Wu Anhua   Wiesner Steve   Xiao Jing   Ericson Katya   Chen Wei   Hall Walter   Low Walter   Ohlfest John  

Journal of Neuro-Oncology, Vol. 83, Iss. 2, 2007-06 ,pp. : 121-131

Springer Publishing Company

Access to resources Recommend Favorite

Fc receptors for IgG and antigen presentation on MHC class I and class II molecules

By Amigorena S.   Bonnerot C.  

Seminars in Immunology, Vol. 11, Iss. 6, 1999-12 ,pp. : 385-390

Academic Press

Access to resources Recommend Favorite